tiprankstipranks
Trending News
More News >
Bastide le Confort Medical SA (FR:BLC)
:BLC
France Market

Bastide le Confort Medical (BLC) Ratios

Compare
9 Followers

Bastide le Confort Medical Ratios

FR:BLC's free cash flow for Q4 2025 was €0.10. For the 2025 fiscal year, FR:BLC's free cash flow was decreased by € and operating cash flow was €0.08. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Sep 24Jun 23Sep 22
Liquidity Ratios
Current Ratio
1.38 1.38 0.97 0.87 1.07
Quick Ratio
1.18 1.18 0.69 0.60 0.72
Cash Ratio
0.13 0.13 0.11 0.16 0.13
Solvency Ratio
0.10 0.10 0.11 0.12 0.13
Operating Cash Flow Ratio
0.36 0.51 0.31 0.40 0.27
Short-Term Operating Cash Flow Coverage
6.44 9.12 1.38 1.19 1.19
Net Current Asset Value
€ -313.14M€ -313.14M€ -357.42M€ -372.58M€ -359.25M
Leverage Ratios
Debt-to-Assets Ratio
0.62 0.62 0.63 0.65 0.66
Debt-to-Equity Ratio
5.70 5.70 5.12 4.88 4.96
Debt-to-Capital Ratio
0.85 0.85 0.84 0.83 0.83
Long-Term Debt-to-Capital Ratio
0.83 0.83 0.78 0.76 0.78
Financial Leverage Ratio
9.16 9.16 8.11 7.50 7.48
Debt Service Coverage Ratio
2.21 2.27 1.33 1.00 1.61
Interest Coverage Ratio
1.39 1.27 1.42 2.21 2.55
Debt to Market Cap
2.03 1.52 2.37 1.55 1.30
Interest Debt Per Share
59.76 59.18 58.44 55.93 58.79
Net Debt to EBITDA
3.80 3.78 3.59 3.98 4.42
Profitability Margins
Gross Profit Margin
9.80%67.80%66.91%65.69%65.51%
EBIT Margin
8.63%8.43%8.28%7.75%7.21%
EBITDA Margin
20.65%20.77%20.24%19.32%19.18%
Operating Profit Margin
9.00%7.97%7.35%7.22%6.95%
Pretax Profit Margin
2.15%2.15%3.12%4.48%4.49%
Net Profit Margin
0.11%0.11%-0.17%2.37%2.92%
Continuous Operations Profit Margin
0.82%0.82%1.79%3.31%3.22%
Net Income Per EBT
5.01%5.01%-5.45%52.92%65.10%
EBT Per EBIT
23.83%26.91%42.40%62.10%64.57%
Return on Assets (ROA)
0.08%0.08%-0.14%1.83%2.16%
Return on Equity (ROE)
0.71%0.73%-1.13%13.74%16.18%
Return on Capital Employed (ROCE)
9.60%8.50%9.03%8.48%7.11%
Return on Invested Capital (ROIC)
3.46%3.07%4.50%5.16%4.55%
Return on Tangible Assets
0.11%0.11%-0.21%6.10%7.24%
Earnings Yield
0.30%0.23%-0.63%5.31%5.27%
Efficiency Ratios
Receivables Turnover
4.97 4.97 4.94 5.29 4.88
Payables Turnover
5.97 2.13 2.28 2.39 2.53
Inventory Turnover
11.09 3.96 2.97 2.89 2.63
Fixed Asset Turnover
2.68 2.68 2.54 2.42 2.25
Asset Turnover
0.74 0.74 0.82 0.77 0.74
Working Capital Turnover Ratio
8.63 14.21 -29.55 -60.00 33.65
Cash Conversion Cycle
45.25 -5.64 36.50 42.51 69.51
Days of Sales Outstanding
73.51 73.51 73.88 69.06 74.74
Days of Inventory Outstanding
32.92 92.20 122.97 126.44 138.95
Days of Payables Outstanding
61.18 171.35 160.35 152.99 144.18
Operating Cycle
106.43 165.71 196.86 195.50 213.69
Cash Flow Ratios
Operating Cash Flow Per Share
9.69 13.63 8.85 11.37 6.36
Free Cash Flow Per Share
1.59 5.59 1.43 4.62 -0.89
CapEx Per Share
8.10 8.04 7.43 6.76 7.25
Free Cash Flow to Operating Cash Flow
0.16 0.41 0.16 0.41 -0.14
Dividend Paid and CapEx Coverage Ratio
1.17 1.68 1.16 1.66 0.84
Capital Expenditure Coverage Ratio
1.20 1.69 1.19 1.68 0.88
Operating Cash Flow Coverage Ratio
0.17 0.25 0.16 0.21 0.11
Operating Cash Flow to Sales Ratio
0.15 0.21 0.12 0.18 0.10
Free Cash Flow Yield
6.75%17.86%7.45%16.14%-2.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
335.58 442.74 -158.66 18.84 18.96
Price-to-Sales (P/S) Ratio
0.36 0.48 0.27 0.45 0.55
Price-to-Book (P/B) Ratio
2.46 3.24 1.79 2.59 3.07
Price-to-Free Cash Flow (P/FCF) Ratio
14.82 5.60 13.42 6.20 -39.83
Price-to-Operating Cash Flow Ratio
2.47 2.30 2.16 2.51 5.55
Price-to-Earnings Growth (PEG) Ratio
-4.86 -2.78 1.48 -1.46 11.57
Price-to-Fair Value
2.46 3.24 1.79 2.59 3.07
Enterprise Value Multiple
5.53 6.07 4.92 6.29 7.31
Enterprise Value
560.38M 619.43M 527.83M 617.71M 656.50M
EV to EBITDA
5.53 6.07 4.92 6.29 7.31
EV to Sales
1.14 1.26 1.00 1.22 1.40
EV to Free Cash Flow
47.52 14.84 49.59 16.86 -100.80
EV to Operating Cash Flow
7.80 6.08 7.99 6.84 14.04
Tangible Book Value Per Share
-16.28 -16.16 -18.33 -46.79 -48.59
Shareholders’ Equity Per Share
9.73 9.66 10.69 11.04 11.51
Tax and Other Ratios
Effective Tax Rate
0.62 0.62 0.43 0.26 0.28
Revenue Per Share
66.25 65.77 71.01 64.00 63.73
Net Income Per Share
0.07 0.07 -0.12 1.52 1.86
Tax Burden
0.05 0.05 -0.05 0.53 0.65
Interest Burden
0.25 0.25 0.38 0.58 0.62
Research & Development to Revenue
0.00 0.00 0.00 <0.01 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.16
Stock-Based Compensation to Revenue
0.00 0.00 0.00 <0.01 <0.01
Income Quality
23.83 65.27 8.95 5.62 3.24
Currency in EUR